Literature DB >> 19740982

Structural and functional analysis of hepatitis C virus strain JFH1 polymerase.

Philip Simister1, Melanie Schmitt, Matthis Geitmann, Oliver Wicht, U Helena Danielson, Rahel Klein, Stéphane Bressanelli, Volker Lohmann.   

Abstract

The hepatitis C virus (HCV) isolate JFH1 represents the only cloned wild-type sequence capable of efficient replication in cell culture, as well as in chimpanzees. Previous reports have pointed to the viral polymerase NS5B as a major determinant for efficient replication of this isolate. To understand the underlying mechanisms, we expressed and purified NS5B of JFH1 and of the closely related isolate J6, which replicates below the limit of detection in cell culture. The JFH1 enzyme exhibited a 5- to 10-fold-higher specific activity in vitro, consistent with the polymerase activity itself contributing to efficient replication of JFH1. The higher in vitro activity of the JFH1 enzyme was not due to increased RNA binding, elongation rate, or processivity of the polymerase but to higher initiation efficiency. By using homopolymeric and heteropolymeric templates, we found that purified JFH1 NS5B was significantly more efficient in de novo initiation of RNA synthesis than the J6 counterpart, particularly at low GTP concentrations, probably representing an important prerequisite for the rapid replication kinetics of JFH1. Furthermore, we solved the crystal structure of JFH1 NS5B, which displays a very closed conformation that is expected to facilitate de novo initiation. Structural analysis shows that this closed conformation is stabilized by a sprinkle of substitutions that together promote extra hydrophobic interactions between the subdomains "thumb" and "fingers." These analyses provide deeper insights into the initiation of HCV RNA synthesis and might help to establish more efficient cell culture models for HCV using alternative isolates.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19740982      PMCID: PMC2772714          DOI: 10.1128/JVI.01008-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Hepatitis C virus: an infectious molecular clone of a second major genotype (2a) and lack of viability of intertypic 1a and 2a chimeras.

Authors:  M Yanagi; R H Purcell; S U Emerson; J Bukh
Journal:  Virology       Date:  1999-09-15       Impact factor: 3.616

2.  Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras.

Authors:  Thomas Pietschmann; Artur Kaul; George Koutsoudakis; Anna Shavinskaya; Stephanie Kallis; Eike Steinmann; Karim Abid; Francesco Negro; Marlene Dreux; Francois-Loic Cosset; Ralf Bartenschlager
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-01       Impact factor: 11.205

3.  Domain identification by iterative analysis of error-scaled difference distance matrices.

Authors:  Thomas R Schneider
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

4.  Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells.

Authors:  MinKyung Yi; Rodrigo A Villanueva; David L Thomas; Takaji Wakita; Stanley M Lemon
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-06       Impact factor: 11.205

5.  Analysis of mutant NS5B proteins encoded by isolates from chimpanzees chronically infected following clonal HCV RNA inoculation.

Authors:  Hong Lou; Youkyung Hwang Choi; John E LaVoy; Marian E Major; Curt H Hagedorn
Journal:  Virology       Date:  2003-12-05       Impact factor: 3.616

6.  Mutations in hepatitis C virus RNAs conferring cell culture adaptation.

Authors:  V Lohmann; F Körner; A Dobierzewska; R Bartenschlager
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

7.  Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site.

Authors:  C A Lesburg; M B Cable; E Ferrari; Z Hong; A F Mannarino; P C Weber
Journal:  Nat Struct Biol       Date:  1999-10

8.  Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity.

Authors:  V Lohmann; F Körner; U Herian; R Bartenschlager
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

9.  The NS3 helicase and NS5B-to-3'X regions are important for efficient hepatitis C virus strain JFH-1 replication in Huh7 cells.

Authors:  Asako Murayama; Tomoko Date; Kenichi Morikawa; Daisuke Akazawa; Michiko Miyamoto; Minako Kaga; Koji Ishii; Tetsuro Suzuki; Takanobu Kato; Masashi Mizokami; Takaji Wakita
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

10.  A cis-acting replication element in the sequence encoding the NS5B RNA-dependent RNA polymerase is required for hepatitis C virus RNA replication.

Authors:  Shihyun You; Decherd D Stump; Andrea D Branch; Charles M Rice
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

View more
  34 in total

1.  Genotype and subtype profiling of PSI-7977 as a nucleotide inhibitor of hepatitis C virus.

Authors:  Angela M Lam; Christine Espiritu; Shalini Bansal; Holly M Micolochick Steuer; Congrong Niu; Veronique Zennou; Meg Keilman; Yuao Zhu; Shuiyun Lan; Michael J Otto; Phillip A Furman
Journal:  Antimicrob Agents Chemother       Date:  2012-03-19       Impact factor: 5.191

2.  Hepatitis C virus nucleotide inhibitors PSI-352938 and PSI-353661 exhibit a novel mechanism of resistance requiring multiple mutations within replicon RNA.

Authors:  Angela M Lam; Christine Espiritu; Shalini Bansal; Holly M Micolochick Steuer; Veronique Zennou; Michael J Otto; Phillip A Furman
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

3.  Construction of a chimeric hepatitis C virus replicon based on a strain isolated from a chronic hepatitis C patient.

Authors:  Huang Cao; Wandi Zhu; Qingxia Han; Rongjuan Pei; Xinwen Chen
Journal:  Virol Sin       Date:  2014-01-20       Impact factor: 4.327

4.  Norovirus RNA-dependent RNA polymerase is phosphorylated by an important survival kinase, Akt.

Authors:  John-Sebastian Eden; Laura J Sharpe; Peter A White; Andrew J Brown
Journal:  J Virol       Date:  2011-08-17       Impact factor: 5.103

5.  Sphingomyelin activates hepatitis C virus RNA polymerase in a genotype-specific manner.

Authors:  Leiyun Weng; Yuichi Hirata; Masaaki Arai; Michinori Kohara; Takaji Wakita; Koichi Watashi; Kunitada Shimotohno; Ying He; Jin Zhong; Tetsuya Toyoda
Journal:  J Virol       Date:  2010-09-15       Impact factor: 5.103

6.  RNA polymerase activity and specific RNA structure are required for efficient HCV replication in cultured cells.

Authors:  Asako Murayama; Leiyun Weng; Tomoko Date; Daisuke Akazawa; Xiao Tian; Tetsuro Suzuki; Takanobu Kato; Yasuhito Tanaka; Masashi Mizokami; Takaji Wakita; Tetsuya Toyoda
Journal:  PLoS Pathog       Date:  2010-04-29       Impact factor: 6.823

7.  Hepatitis C virus-induced prion protein expression facilitates hepatitis C virus replication.

Authors:  Huixia Zhang; Shanshan Gao; Rongjuan Pei; Xinwen Chen; Chaoyang Li
Journal:  Virol Sin       Date:  2017-10-25       Impact factor: 4.327

8.  Robust full-length hepatitis C virus genotype 2a and 2b infectious cultures using mutations identified by a systematic approach applicable to patient strains.

Authors:  Yi-Ping Li; Santseharay Ramirez; Judith M Gottwein; Troels K H Scheel; Lotte Mikkelsen; Robert H Purcell; Jens Bukh
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-30       Impact factor: 11.205

9.  Two crucial early steps in RNA synthesis by the hepatitis C virus polymerase involve a dual role of residue 405.

Authors:  Nathalie Scrima; Célia Caillet-Saguy; Michel Ventura; Déborah Harrus; Thérèse Astier-Gin; Stéphane Bressanelli
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

10.  Structure of hepatitis C virus polymerase in complex with primer-template RNA.

Authors:  Ralph T Mosley; Thomas E Edwards; Eisuke Murakami; Angela M Lam; Rena L Grice; Jinfa Du; Michael J Sofia; Philip A Furman; Michael J Otto
Journal:  J Virol       Date:  2012-04-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.